These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31290716)

  • 21. Healthcare resource utilization and costs in patients with a newly confirmed diagnosis of lupus nephritis in the United States over a 5-year follow-up period.
    Bell CF; Wu B; Huang SP; Rubin B; Averell CM; Chastek B; Hulbert EM
    BMC Health Serv Res; 2024 May; 24(1):691. PubMed ID: 38822336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B.
    Nguyen MH; Burak Ozbay A; Liou I; Meyer N; Gordon SC; Dusheiko G; Lim JK
    J Hepatol; 2019 Jan; 70(1):24-32. PubMed ID: 30287341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data.
    Strand V; Shah R; Atzinger C; Zhou J; Clewell J; Ganguli A; Tundia N
    Curr Med Res Opin; 2020 Jan; 36(1):161-168. PubMed ID: 31433680
    [No Abstract]   [Full Text] [Related]  

  • 24. Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database.
    Bhowmik D; Hines DM; Intorcia M; Wade RL
    J Med Econ; 2018 Jun; 21(6):622-628. PubMed ID: 29571273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and economic burden of breakthrough seizures.
    Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
    Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthcare resource utilization and costs among patients with alpha-1 antitrypsin deficiency with liver and/or lung disease: a longitudinal retrospective study in the USA.
    Hagiwara M; Divino V; Munnangi S; Delegge M; Park S; Marins EG; Ren K; Strange C
    J Comp Eff Res; 2024 Jun; 13(6):e230186. PubMed ID: 38696696
    [No Abstract]   [Full Text] [Related]  

  • 27. Real-world health plan claims analysis of differences in healthcare utilization and total cost in patients suffering from cluster headaches and those without headache-related conditions.
    Polson M; Lord TC; Evangelatos TM; Lopes M; Santaniello BL
    Am J Manag Care; 2017 Nov; 23(16 Suppl):S295-S299. PubMed ID: 29144719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
    You JH; Sahota DS; Yuen PM
    Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital Therapeutic.
    Velez FF; Anastassopoulos KP; Colman S; Shah N; Kauffman L; Murphy SM; Ruetsch C; Maricich YA
    Adv Ther; 2022 Sep; 39(9):4131-4145. PubMed ID: 35799080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healthcare utilization and direct medical costs of Huntington's disease among Medicaid beneficiaries in the United States.
    Patel AM; Chang E; Paydar C; Reddy SR
    J Med Econ; 2023; 26(1):811-820. PubMed ID: 37285853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare resource utilization and costs in individuals with Huntington's disease by disease stage in a US population.
    Exuzides A; To TM; Abbass IM; Ta JT; Patel AM; Surinach A; Fuller RLM; Luo J
    J Med Econ; 2022; 25(1):722-729. PubMed ID: 35608039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The direct and indirect cost burden of clinically significant and symptomatic uterine fibroids.
    Lee DW; Ozminkowski RJ; Carls GS; Wang S; Gibson TB; Stewart EA
    J Occup Environ Med; 2007 May; 49(5):493-506. PubMed ID: 17495692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
    Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
    Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthcare resource utilization and costs in patients with HIV-1 who switched first-line antiretroviral therapy.
    Mao J; Johnson MP; McPheeters JT; Prajapati G; Beyer AP
    Curr Med Res Opin; 2019 Nov; 35(11):1945-1953. PubMed ID: 31311342
    [No Abstract]   [Full Text] [Related]  

  • 35. True Costs of Uterine Artery Embolization: Time-Driven Activity-Based Costing in Interventional Radiology Over a 3-Year Period.
    Bulman JC; Kim NH; Kaplan RS; Schroeppel DeBacker SE; Brook OR; Sarwar A
    J Am Coll Radiol; 2024 May; 21(5):721-728. PubMed ID: 38220041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commercial claims costs related to health care resource use associated with a diagnosis of peanut allergy.
    Shaker M; Chalil JM; Tran O; Vlahiotis A; Shah H; King T; Green TD; Greenhawt M
    Ann Allergy Asthma Immunol; 2020 Apr; 124(4):357-365.e1. PubMed ID: 31954759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine.
    Molife C; Haynes VS; Nyhuis A; Faries DE; Gelwicks S; Kelsey DK; Alatorre CI
    Curr Med Res Opin; 2018 Apr; 34(4):619-632. PubMed ID: 29298540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burden of symptomatic uterine fibroids in Canadian women: a cohort study.
    Laberge PY; Vilos GA; Vilos AG; Janiszewski PM
    Curr Med Res Opin; 2016; 32(1):165-75. PubMed ID: 26455364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excess healthcare resource utilization and healthcare costs among privately and publicly insured patients with major depressive disorder and acute suicidal ideation or behavior in the United States.
    Zhdanava M; Voelker J; Pilon D; Joshi K; Morrison L; Sheehan JJ; Vermette-Laforme M; Lefebvre P; Citrome L
    J Affect Disord; 2022 Aug; 311():303-310. PubMed ID: 35597466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis.
    Amand C; Tong S; Kieffer A; Kyaw MH
    BMC Health Serv Res; 2018 Apr; 18(1):294. PubMed ID: 29678177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.